Supernus Pharmaceuticals, Inc.
DE ˙ DB ˙ US8684591089
37,80 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:S49 / Supernus Pharmaceuticals, Inc.
InstitutionUs Bancorp \de\
Latest Disclosed Ownership1,840 shares
Latest Disclosed Value $ 95,109
Us Bancorp \de\ reports 3.55% increase in ownership of S49 / Supernus Pharmaceuticals, Inc.

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 1,840 shares of Supernus Pharmaceuticals, Inc. (DE:S49) valued at $79,488 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 1,777 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of 3.55% during the quarter. The current value of the position is $69,552 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,840 63 3.55 95 7.95 0.0000
2026-01-30 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 1,777 -618 -25.80 88 -22.81 0.0001
2025-11-12 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 2,395 -3,170 -56.96 114 -34.86 0.0001
2025-07-24 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 5,565 -596 -9.67 175 -12.94 0.0002
2025-05-08 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 6,161 104 1.72 202 -8.22 0.0003
2025-02-05 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 6,057 18 0.30 219 16.49 0.0003
2024-10-28 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 6,039 76 1.27 188 18.24 0.0002
2024-08-07 2024-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 5,963 -88 -1.45 160 -22.82 0.0002
2024-05-08 2024-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 6,051 453 8.09 206 27.16 0.0003
2024-02-09 2023-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 5,598 -68 -1.20 162 3.85 0.0002
2023-11-03 2023-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 5,666 -385 -6.36 156 -13.81 0.0003
2023-08-10 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 6,051 -218 -3.48 182 -20.26 0.0003
2023-05-09 2023-03-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 6,269 923 17.27 227 19.47 0.0004
2023-02-13 2022-12-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 5,346 -513 -8.76 191 -4.04 0.0003
2022-10-27 2022-09-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 5,859 -835 -12.47 198 2.06 0.0004
2022-08-01 2022-06-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 6,694 -2,879 -30.07 194 -37.22 0.0004
2022-05-11 2022-03-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 9,573 -3,077 -24.32 309 -16.26 0.0005
2022-02-11 2021-12-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 12,650 -266 -2.06 369 7.27 0.0006
2021-11-10 2021-09-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 12,916 -769 -5.62 344 -18.29 0.0006
2021-08-05 2021-06-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 13,685 619 4.74 421 23.10 0.0008
2021-04-28 2021-03-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 13,066 1,784 15.81 342 20.42 0.0007
2021-02-04 2020-12-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,282 -1,664 -12.85 284 5.58 0.0006
2020-11-10 2020-09-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 12,946 -3,822 -22.79 269 -32.58 0.0007
2020-08-07 2020-06-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 16,768 -3,501 -17.27 399 9.32 0.0010
2020-05-13 2020-03-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 20,269 -527 -2.53 365 -25.96 0.0011
2020-02-04 2019-12-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 20,796 -5,802 -21.81 493 -32.65 0.0013
2019-11-08 2019-09-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 26,598 -5,638 -17.49 732 -31.40 0.0020
2019-08-13 2019-06-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 32,236 -8,018 -19.92 1,067 -24.38 0.0030
2019-05-08 2019-03-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 40,254 4,268 11.86 1,411 18.08 0.0041
2019-02-13 2018-12-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 35,986 7,267 25.30 1,195 -17.36 0.0039
2018-10-31 2018-09-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 28,719 4,846 20.30 1,446 1.26 0.0042
2018-08-08 2018-06-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 23,873 -917 -3.70 1,428 25.70 0.0044
2018-05-08 2018-03-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 24,790 -2,902 -10.48 1,136 2.90 0.0035
2018-02-02 2017-12-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 27,692 -4,391 -13.69 1,104 -14.02 0.0034
2017-11-13 2017-09-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 32,083 -5,939 -15.62 1,284 -21.66 0.0041
2017-07-19 2017-06-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 38,022 -2,968 -7.24 1,639 27.65 0.0055
2017-05-03 2017-03-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 40,990 -9,108 -18.18 1,284 1.50 0.0044
2017-02-08 2016-12-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 50,098 -4,410 -8.09 1,265 -6.30 0.0046
2016-11-04 2016-09-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 54,508 -5,296 -8.86 1,350 10.84 0.0050
2016-08-10 2016-06-30 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 59,804 1,205 2.06 1,218 36.39 0.0046
2016-05-13 2016-03-31 13F SUPERNUS PHAMACEUTICALS COMMON STOCK 868459108 58,599 -7,985 -11.99 893 -0.11 0.0035
2016-02-10 2015-12-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 66,584 34,405 106.92 894 98.23 0.0036
2015-11-16 2015-09-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 32,179 28,441 760.86 451 615.87 0.0019
2015-08-10 2015-06-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 3,738 -8,027 -68.23 63 -55.63 0.0002
2015-05-08 2015-03-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,765 0 0.00 142 44.90 0.0005
2015-02-13 2014-12-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,765 715 6.47 98 2.08 0.0004
2014-11-14 2014-09-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,050 0 0.00 96 -20.66 0.0004
2014-08-14 2014-06-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,050 0 0.00 121 22.22 0.0005
2014-05-14 2014-03-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,050 0 0.00 99 19.28 0.0004
2014-02-13 2013-12-31 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,050 0 0.00 83 2.47 0.0003
2013-11-07 2013-09-30 13F SUPERNUS PHARMACEUTICALS COMMON STOCK 868459108 11,050 11,050 81 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.